Fort Wayne Medical Oncology and Hematology Joins American Oncology Network
January 07, 2025 08:00 ET
|
American Oncology Network
Fort Wayne Medical Oncology and Hematology, a trusted name in NE Indiana cancer care, is proud to announce it has joined American Oncology Network.
Inactivating Mutations in Scaffold Component of PP2A, the Target Enzyme of LIXTE Biotechnology’s Clinical Compound LB-100, are Associated with Exceptionally Long Survival of Patients with Ovarian Clear Cell Cancer Treated with Immunotherapy
March 22, 2022 08:30 ET
|
Lixte Biotechnology Holdings, Inc.
Outside research reports that immune checkpoint therapy of patients with ovarian clear cell carcinomas with mutations reducing PP2A activity in their cancers (loss-of-function mutations) correlates...
FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE GYNECOLOGIC ONCOLOGIST JESSICA STINE, MD NAMED NATIONAL GYNECOLOGIC ONCOLOGY OBSERVATION SITE
November 03, 2021 09:30 ET
|
Florida Cancer Specialists & Research Institute
Tampa, Fla., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Jessica Stine, MD, gynecologic oncologist with Florida Cancer Specialists & Research Institute (FCS), and an advanced robotic surgeon who performs...
Florida Cancer Specialists & Research Institute Celebrates Opening of New Cancer Center in Tallahassee
April 29, 2021 08:28 ET
|
Florida Cancer Specialists
Fort Myers, Fla., April 29, 2021 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute (FCS) physicians and senior leaders gathered this week for a ribbon-cutting ceremony to...
Poster on Celsion Corporation’s Phase I/II OVATION 2 Study Presented at the Society of Gynecologic Oncology Virtual Annual Meeting on Women’s Cancer
April 01, 2021 08:30 ET
|
Celsion CORP
Company reports further strengthening of R0 resection results in patients treated with GEN-1 LAWRENCEVILLE, N.J., April 01, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a...
Poster on Celsion Corporation’s Phase I/II OVATION 2 Study to be Presented at the Society of Gynecologic Oncology Virtual Annual Meeting on Women’s Cancer
March 02, 2021 08:45 ET
|
Celsion CORP
LAWRENCEVILLE, N.J., March 02, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines,...
Global Gynecology Partnering Deal Trends, Players and Financials Directory 2010-2020
December 11, 2020 09:33 ET
|
Research and Markets
Dublin, Dec. 11, 2020 (GLOBE NEWSWIRE) -- The "Global Gynecology Partnering 2010-2020: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering. Global...
Global Gynecology Partnering Deal Trends, Players and Financials Directory 2010-2020
September 24, 2020 04:49 ET
|
Research and Markets
Dublin, Sept. 24, 2020 (GLOBE NEWSWIRE) -- The "Global Gynecology Partnering 2010-2020: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering. Global...
Margarett C. Ellison, MD of Gynecologic Oncology of Tallahassee Joins Florida Cancer Specialists & Research Institute
April 15, 2020 09:17 ET
|
Florida Cancer Specialists
Tallahassee, Fla., April 15, 2020 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute (FCS) is pleased to announce the addition of gynecologic-oncologist Dr. Margarett C. Ellison...
Celsion Announces Publication of Results of National Institutes of Health (NIH) Analysis of ThermoDox® in Journal of Vascular and Interventional Radiology
August 13, 2019 08:00 ET
|
Celsion CORP
NIH’s Independent Analysis of Celsion’s Phase III HEAT Study Confirms Increasing Radiofrequency Ablation (RFA) Heating Time + ThermoDox® Improves Overall Survival with Significance in Patients with...